close 73% van de retail rekeningen verliezen gelden met de handel in CFD`s bij deze aanbieder. Investeringen zijn risicovol en zijn niet geschikt voor alle beleggers. CFD`s zijn complexe instrumenten met een hoog risico om snel gelden te verliezen vanwege het hefboomeffect. 73% van de retail beleggers lijdt verlies bij het handelen in CFD`s met deze aanbieder. Het is belangrijk dat u goed begrijpt hoe CFD`s werken en dat u nagaat of u zich het hoge risico op verlies kunt permitteren.
ZoekenZoeken
Change languageNederlands
Dashboard

LLY

1,105.05

-0.35%↓

JNJ

207.73

+0.45%↑

ABBV

227.54

-1.85%↓

UNH

329.68

+1.07%↑

AZN

93.37

+0.12%↑

LLY

1,105.05

-0.35%↓

JNJ

207.73

+0.45%↑

ABBV

227.54

-1.85%↓

UNH

329.68

+1.07%↑

AZN

93.37

+0.12%↑

LLY

1,105.05

-0.35%↓

JNJ

207.73

+0.45%↑

ABBV

227.54

-1.85%↓

UNH

329.68

+1.07%↑

AZN

93.37

+0.12%↑

LLY

1,105.05

-0.35%↓

JNJ

207.73

+0.45%↑

ABBV

227.54

-1.85%↓

UNH

329.68

+1.07%↑

AZN

93.37

+0.12%↑

LLY

1,105.05

-0.35%↓

JNJ

207.73

+0.45%↑

ABBV

227.54

-1.85%↓

UNH

329.68

+1.07%↑

AZN

93.37

+0.12%↑

Home・Aandelen Lijst・Karyopharm Therapeutics Inc
Search

Karyopharm Therapeutics Inc

Open

SectorGezondheidszorg

5.51 0.36

Strong Buy

Prijsupdate 26 nov 2025, 20:59 UTC

BuySell

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

5.51

Max

5.62

Belangrijke statistieken

By Trading Economics

Inkomsten

4.1M

-33M

Verkoop

6.1M

44M

EPS

-3.82

Winstmarge

-75.213

Werknemers

279

EBITDA

1.8M

-23M

Aanbevelingen

By TipRanks

Aanbevelingen

Strong Buy

12 Maanden Prognose

+149.19% upside

Marktinformatie

By TradingEconomics

Marktkapitalisatie

-7.4M

95M

Vorige openingsprijs

5.15

Vorige sluitingsprijs

5.51

Nieuwssentiment

By Acuity

50%

50%

163 / 374 Rangschikking in Healthcare

Technische score

By Trading Central

Vertrouwen

Bullish Evidence

5.9501 / 7.66 Steun & Weerstand

Karyopharm Therapeutics Inc Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

26 nov 2025, 17:44 UTC

Winsten
Belangrijke Marktbewegers

Deere Warns of Tough Year Ahead as Earnings, Sales Fall -- Update

DJ

Lezen

27 nov 2025, 00:00 UTC

Marktinformatie

Rio Tinto's Coming Investor Briefing Seen Focused on Costs, Lithium, Asset Sales -- Market Talk

DJ

Lezen

26 nov 2025, 23:47 UTC

Marktinformatie

Nikkei May Rise as Fears About Potential AI Bubble Ease -- Market Talk

DJ

Lezen

26 nov 2025, 23:28 UTC

Marktinformatie

Mortgage Refinancing in New Zealand Will Spur Recovery -- Market Talk

DJ

Lezen

26 nov 2025, 23:21 UTC

Marktinformatie

Global Forex and Fixed Income Roundup: Market Talk

DJ

Lezen

26 nov 2025, 23:21 UTC

Marktinformatie

RBNZ Rate Cuts Finally Getting Traction With Consumers -- Market Talk

DJ

Lezen

26 nov 2025, 23:02 UTC

Marktinformatie

Steelmaking Coal Price Signal Knocked by China Import Shift -- Market Talk

DJ

Lezen

26 nov 2025, 21:38 UTC

Winsten

These Stocks Moved the Most Today: Alphabet, Nvidia, AMD, Apple, Dell, Robinhood, Deere, HP Inc., Urban Outfitters, and More -- Barrons.com

DJ

Lezen

26 nov 2025, 21:25 UTC

Winsten

Li Auto Posts Surprise Loss, Stock Rises. What's Next for Its Diving EV Sales. -- Barrons.com

DJ

Lezen

26 nov 2025, 21:17 UTC

Acquisities, Fusies, Overnames

Commercial Metals Co Announces Closing of $2B Senior Notes Offering

DJ

Lezen

26 nov 2025, 21:16 UTC

Winsten

Deere Beat Earnings Estimates. Why the Stock Is Falling. -- Barrons.com

DJ

Lezen

26 nov 2025, 21:09 UTC

Winsten

Roblox Isn't Playing Games. Why the Stock Could -2-

DJ

Lezen

26 nov 2025, 21:09 UTC

Winsten

Roblox Isn't Playing Games. Why the Stock Could Jump 50%. -- Barrons.com

DJ

Lezen

26 nov 2025, 20:27 UTC

Acquisities, Fusies, Overnames

Charter Communications Stock Is a Disaster. The Answer Could Be a 10% Dividend. -- Barrons.com

DJ

Lezen

26 nov 2025, 20:25 UTC

Acquisities, Fusies, Overnames

Charter Communications Stock Is a Disaster. The Answer Could Be a 10% Dividend. -- Barrons.com

DJ

Lezen

26 nov 2025, 20:15 UTC

Winsten

These Stocks Are Moving the Most Today: Alphabet, Nvidia, AMD, Apple, Dell, Robinhood, Deere, HP Inc., Urban Outfitters, and More -- Barrons.com

DJ

Lezen

26 nov 2025, 20:08 UTC

Marktinformatie

Oil Futures Settle Higher in Choppy Trade -- Market Talk

DJ

Lezen

26 nov 2025, 20:06 UTC

Marktinformatie

U.S. Natural Gas Settles Higher Ahead of Holiday -- Market Talk

DJ

Lezen

26 nov 2025, 19:30 UTC

Winsten

These Stocks Are Moving the Most Today: Alphabet, Nvidia, AMD, Apple, Dell, Robinhood, Deere, HP Inc., Urban Outfitters, and More -- Barrons.com

DJ

Lezen

26 nov 2025, 19:21 UTC

Acquisities, Fusies, Overnames

Teck Resources: ISS and Glass Lewis Recommend Teck Hldrs Vote for Anglo American Deal

DJ

Lezen

26 nov 2025, 18:43 UTC

Marktinformatie

U.S. Natural Gas Storage Down for Second Straight Week -- Market Talk

DJ

Lezen

26 nov 2025, 18:41 UTC

Marktinformatie

U.S. Oil Rig Count Falls By 12 to 407 -- Market Talk

DJ

Lezen

26 nov 2025, 18:19 UTC

Winsten

Workday Beat Earnings Estimates. The Stock Is Down 10% Anyway. -- Barrons.com

DJ

Lezen

26 nov 2025, 17:51 UTC

Winsten

Deere Forecasts Higher Tariff Costs, Less Profit in 2026 -- WSJ

DJ

Lezen

26 nov 2025, 17:50 UTC

Winsten

These Stocks Are Moving the Most Today: Alphabet, Nvidia, AMD, Apple, Dell, Robinhood, Deere, HP Inc., Urban Outfitters, and More -- Barrons.com

DJ

Lezen

26 nov 2025, 17:20 UTC

Marktinformatie
Acquisities, Fusies, Overnames

Energy & Utilities Roundup: Market Talk

DJ

Lezen

26 nov 2025, 17:20 UTC

Marktinformatie

Auto & Transport Roundup: Market Talk

DJ

Lezen

26 nov 2025, 17:20 UTC

Marktinformatie

Health Care Roundup: Market Talk

DJ

Lezen

26 nov 2025, 17:16 UTC

Winsten
Acquisities, Fusies, Overnames

Blue Owl Is Having a Rough Year. Its Co-CEO Says -2-

DJ

Lezen

26 nov 2025, 17:16 UTC

Winsten
Acquisities, Fusies, Overnames

Blue Owl Is Having a Rough Year. Its Co-CEO Says Investors' Fears Are 'Ungrounded.' -- Barrons.com

DJ

Lezen

Peer Vergelijking

Prijswijziging

Karyopharm Therapeutics Inc Prognose

Koersdoel

By TipRanks

149.19% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 13.83 USD  149.19%

Hoogste 21 USD

Laagste 6 USD

Gebaseerd op 6 Wall Street-analisten die 12-maands prijsdoelen bieden voor Karyopharm Therapeutics Inc - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Strong Buy

6 ratings

5

Buy

1

Hold

0

Sell

Gebaseerd op 6 analisten die aandelenratings hebben gegeven aan Karyopharm Therapeutics Inc - Dist in de afgelopen 3 maanden.

Technische score

By Trading Central

5.9501 / 7.66Steun & Weerstand

Korte Termijn

Bullish Evidence

Recent bullish events outweigh bearish events.

Gemiddeld Termijn

Strong Bearish Evidence

All events are bearish.

Lange Termijn

No Evidence

There are no events.

Sentiment

By Acuity

163 / 374 Rangschikking in Gezondheidszorg

Nieuwssentiment

Neutral

Volatiliteit

Onder gemiddelde

Nieuws Volume (RCV)

Onder gemiddelde

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

$

Andere aandelen uit de sector

LLY

Eli Lilly and Co.

1,105.05

↓-0.35%

JNJ

Johnson and Johnson

207.73

↑ +0.45%

ABBV

AbbVie Inc

227.54

↓-1.85%

UNH

UnitedHealth Group Inc

329.68

↑ +1.07%

AZN

AstraZeneca PLC ADR

93.37

↑ +0.12%
help-icon Live chat